GCTK GlucoTrack, Inc.
USHealthcareAs of 2026-07-10 16:00
Why GCTK matters now
GlucoTrack, Inc. (GCTK) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.42 with +7.44% on the session and $236.9K in market capitalization; recent performance reads 1-month -33.57% and YTD -90.48%.
The latest financial table shown here is Q1 2026, with revenue of $0.00, net income of $-4.3M, and EPS of $2.65. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -7860.1%.
The latest indexable market news headline is "Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform" from GlobeNewsWire.
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.71
P/S
0.00
EV/EBITDA
0.22
DCF Value
$6.80
FCF Yield
-7860.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-582.0%
ROA
-387.7%
ROIC
1378.9%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $0.00 | $-4.3M | $2.65 |
| Q4 2025 | $0.00 | $-3.6M | $-3.98 |
| FY 2025 | $0.00 | $-19.4M | $-21.56 |
| Q3 2025 | $0.00 | $-4.2M | $4.64 |
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
IL
Exchange
—
Beta
0.67
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.